3, 5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo [4,5-d]pyrimidin-2-one compounds and prodrugs thereof

Details for Australian Patent Application No. 2005316397 (hide)

Owner Anadys Pharmaceuticals, Inc.

Inventors Haley, Gregory J.; Xiang, Alan Xin; Rueden, Erik J.; Lennox, Joseph R.; Webber, Stephen E.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005316397

PCT Pub. Number WO2006/066080

Priority 60/636,634 17.12.04 US; 60/636,633 17.12.04 US

Filing date 16 December 2005

Wipo publication date 22 June 2006

Acceptance publication date 2 February 2012

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/066080 Priority application(s): WO2006/066080

2 February 2012 Application Accepted

  Published as AU-B-2005316397

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005316403-Antiangiogenesis therapy of autoimmune disease in patients who have failed prior therapy

2005316396-Pyridazinone compounds